Location: NEW YORK, NY
CIK: 0001633313 · Show all filings
Period: Q3 2025 (← Previous) (Next →)
Filing Date: Nov 14, 2025
Total Value ($000): $7,736,501 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ASND | ASCENDIS PHARMA | 5,110,000 | $1,015,919 | 13.1% | $129.64 | — | Sponsored ADR | 04351P101 |
| UTHR | UNITED THERAPEUTICS CORP | 2,022,222 | $847,736 | 11.0% | $134.94 | +149.2% | Common | 91307C102 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 1,833,000 | $840,724 | 10.9% | $138.83 | +168.7% | Common | 558868105 |
| ARGX | ARGENX SE | 990,000 | $730,184 | 9.4% | $186.36 | — | Sponsored ADR | 04016X101 |
| KRYS | KRYSTAL BIOTECH INC | 2,777,777 | $490,361 | 6.3% | $91.68 | +63.3% | Common | 501147102 |
| ARWR | ARROWHEAD PHARMACEUTICALS INC. | 10,900,000 | $375,941 | 4.9% | $29.07 | -24.4% | Common | 04280A100 |
| KYMR | KYMERA THERAPEUTICS INC | 6,350,000 | $359,410 | 4.6% | $35.30 | +27.8% | Common | 501575104 |
| — | MERUS N V | 3,542,500 | $333,526 | 4.3% | $46.32 | — | Common | N5749R100 |
| RNAM | AVIDITY BIOSCIENCES INC | 7,645,000 | $333,093 | 4.3% | $23.88 | +69.3% | Common | 05370A108 |
| APLS | APELLIS PHARMACEUTICALS INC. | 12,222,222 | $276,589 | 3.6% | $47.01 | -50.4% | Common | 03753U106 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 10,808,080 | $262,096 | 3.4% | $19.57 | — | SPONSORED ADR | 152309100 |
| QURE | UNIQURE NV | 4,444,444 | $259,422 | 3.4% | $11.96 | +51.8% | Common | N90064101 |
| XENE | XENON PHARMACEUTICALS INC | 5,400,000 | $216,810 | 2.8% | $19.12 | +84.2% | Common | 98420N105 |
| — | AKERO THERAPEUTICS INC | 3,955,555 | $187,810 | 2.4% | $52.68 | — | Common | 00973Y108 |
| VERA | VERA THERAPEUTICS INC | 6,210,000 | $180,463 | 2.3% | $36.12 | -36.0% | Common | 92337R101 |
| SLNO | SOLENO THERAPEUTICS INC | 2,577,777 | $174,258 | 2.3% | $47.37 | +56.5% | Common | 834203309 |
| GPCR | STRUCTURE THERAPEUTICS INC. | 5,155,555 | $144,356 | 1.9% | $28.00 | — | SPONSORED ADS | 86366E106 |
| — | TOURMALINE BIO INC | 2,555,555 | $122,232 | 1.6% | $23.05 | — | Common | 89157D105 |
| OCUL | OCULAR THERAPEUTIX INC | 10,250,000 | $119,823 | 1.5% | $8.37 | +42.8% | Common | 67576A100 |
| FOLD | AMICUS THERAPEUTICS INC. | 15,025,000 | $118,397 | 1.5% | $10.47 | -32.0% | Common | 03152W109 |
| — | 89BIO INC | 6,387,790 | $93,901 | 1.2% | $7.76 | — | Common | 282559103 |
| TSHA | TAYSHA GENE THERAPIES INC | 21,700,000 | $70,959 | 0.9% | $2.05 | +38.2% | Common | 877619106 |
| ALKS | ALKERMES PLC | 2,240,000 | $67,200 | 0.9% | $28.91 | -2.5% | Common | G01767105 |
| ORKA | ORUKA THERAPEUTICS INC | 1,333,340 | $25,640 | 0.3% | $14.82 | 0.0% | Common | 687604108 |
| SEPN | SEPTERNA INC | 1,337,500 | $25,158 | 0.3% | $20.93 | -37.3% | Common | 81734D104 |
| MNKD | MANNKIND CORP | 4,468,877 | $23,998 | 0.3% | $3.56 | +23.4% | Common | 56400P706 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 2,000,000 | $14,340 | 0.2% | $37.53 | +38.9% | CLASS A ORD | 61559X104 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 1,250,000 | $9,488 | 0.1% | $10.72 | -22.3% | Common | 09058V103 |
| WHWK | WHITEHAWK THERAPEUTICS INC | 2,849,402 | $5,414 | 0.1% | $24.27 | -92.4% | Common | 00032Q104 |
| TNGX | TANGO THERAPEUTICS INC | 545,000 | $4,578 | 0.1% | $6.77 | 0.0% | Common | 87583X109 |
| UTHR | UNITED THERAPEUTICS CORP | 200,000 | $4,440 | 0.1% | $134.94 | +149.2% | Call | 91307C102 |
| GPCR | STRUCTURE THERAPEUTICS INC. | 250,000 | $2,238 | 0.0% | $28.00 | — | Call | 86366E106 |